Though oncostatin M (OSM) is a potent mediator of the inflammatory rea
ction, its role in inflammation and bone resorption is still unclear,
A long-term bone-marrow culture system is usually developed to allow t
he formation of multinucleated cells (MNC) and was used here to define
the effects of human recombinant OSM on human MNC formation, OSM sign
ificantly upregulated (1.9- to 5.6-fold) the number of MNC in these cu
ltures in a dose-and time-dependent manner, Cell nucleation and tartra
te-resistant acid phosphatase activity were also increased, MNC did no
t display osteoclast characteristics, such as response to calcitonin a
nd failure to resorb dentin surface, However, they expressed a non-spe
cific ar-naphthyl acetate esterase as well as macrophage differentiati
on antigens (CD11b, CD13 and CD33) and were able to perform phagocytos
is, Similar effects were observed after addition of 1 alpha,25-dihydro
xyvitamin D3, Moreover, in these culture conditions, human bone-marrow
mononuclear cells were capable of low-grade resorption in the presenc
e of bone-marrow stromal cells, This low-grade resorption was signific
antly inhibited by addition of 25 ng/ml OSM, Our data demonstrate for
the first time that human recombinant OSM significantly stimulates the
formation of MNC and could be involved in the inflammatory process vi
a macrophage-polykaryon formation from human bone marrow. (C) 1998 Aca
demic Press Limited.